143 related articles for article (PubMed ID: 35326407)
1. Polymorphism of Baculoviral Inhibitor of Apoptosis Repeat-Containing 5 (BIRC5) Can Be Associated with Clinical Outcome of Non-Small Cell Lung Cancer.
Szczyrek M; Mlak R; Szudy-Szczyrek A; Wojas-Krawczyk K; Kędziora K; Milanowski J
Cells; 2022 Mar; 11(6):. PubMed ID: 35326407
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in a miR-335 binding site in BIRC5 alters susceptibility to lung cancer in Chinese Han populations.
Zu Y; Ban J; Xia Z; Wang J; Cai Y; Ping W; Sun W
Biochem Biophys Res Commun; 2013 Jan; 430(2):529-34. PubMed ID: 23232114
[TBL] [Abstract][Full Text] [Related]
3. BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients.
Hmeljak J; Erčulj N; Dolžan V; Kern I; Cör A
J Cancer Res Clin Oncol; 2011 Nov; 137(11):1641-51. PubMed ID: 21861135
[TBL] [Abstract][Full Text] [Related]
4. Influence of survivin (BIRC5) and caspase-9 (CASP9) functional polymorphisms in renal cell carcinoma development: a study in a southern European population.
Marques I; Teixeira AL; Ferreira M; Assis J; Lobo F; Maurício J; Medeiros R
Mol Biol Rep; 2013 Aug; 40(8):4819-26. PubMed ID: 23645041
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of ERCC1 single-nucleotide polymorphism in patients receiving platinum-based chemotherapy for locally-advanced and advanced non-small cell lung cancer--a pilot study.
Krawczyk P; Wojas-Krawczyk K; Mlak R; Kucharczyk T; Biernacka B; Milanowski J
Folia Histochem Cytobiol; 2012 Apr; 50(1):80-6. PubMed ID: 22532140
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy.
Lee SY; Kang HG; Yoo SS; Kang YR; Choi YY; Lee WK; Choi JE; Jeon HS; Shin KM; Oh IJ; Kim KS; Lee J; Cha SI; Kim CH; Kim YC; Park JY
Lung Cancer; 2013 Nov; 82(2):330-9. PubMed ID: 23973201
[TBL] [Abstract][Full Text] [Related]
7. The effect of polymorphisms in the promoter of the BIRC5 gene on the risk of oesophageal squamous cell carcinoma and patient's outcomes.
Wang N; Li Y; Zhou RM; Cui SJ; Cao SR; Huang X; Huo XR; Shan BE
Mutagenesis; 2019 Dec; 34(4):307-313. PubMed ID: 31165868
[TBL] [Abstract][Full Text] [Related]
8. A candidate single nucleotide polymorphism in the 3' untranslated region (rs17878624) of survivin gene for NSCLC.
Aynaci E; Coskunpinar E; Yildiz P
Cell Mol Biol (Noisy-le-grand); 2018 Mar; 64(4):119-122. PubMed ID: 29631694
[TBL] [Abstract][Full Text] [Related]
9. BIRC5: A novel therapeutic target for lung cancer stem cells and glioma stem cells.
Kahm YJ; Kim RK
Biochem Biophys Res Commun; 2023 Nov; 682():141-147. PubMed ID: 37806253
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of survivin polymorphisms on non-small cell lung cancer survival.
Dai J; Jin G; Dong J; Chen Y; Xu L; Hu Z; Shen H
J Thorac Oncol; 2010 Nov; 5(11):1748-54. PubMed ID: 20881643
[TBL] [Abstract][Full Text] [Related]
11. The impact of functional LIG4 polymorphism on platinum-based chemotherapy response and survival in non-small cell lung cancer.
Jiang YH; Xu XL; Ruan HH; Xu WZ; Li D; Feng JG; Han QB; Mao WM
Med Oncol; 2014 May; 31(5):959. PubMed ID: 24722796
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer.
Zhao W; Hu L; Xu J; Shen H; Hu Z; Ma H; Shu Y; Shao Y; Yin Y
Cancer Chemother Pharmacol; 2013 May; 71(5):1287-95. PubMed ID: 23479135
[TBL] [Abstract][Full Text] [Related]
13. Role of survivin re-expression in the development and progression of non-small cell lung cancer.
Javid J; Mir R; Julka PK; Ray PC; Saxena A
Tumour Biol; 2015 Jul; 36(7):5543-50. PubMed ID: 25677909
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of STMN1 gene promoter polymorphism (-2166T>C) in patients with advanced NSCLC treated with the combination of platinum compounds and vinorelbine.
Mlak R; Krawczyk P; Ciesielka M; Homa I; Powrózek T; Prendecka M; Kozioł P; Milanowski J; Małecka-Massalska T
Cancer Chemother Pharmacol; 2015 Sep; 76(3):621-9. PubMed ID: 26220844
[TBL] [Abstract][Full Text] [Related]
15. Association between survivin genetic polymorphisms and epidermal growth factor receptor mutation in non-small-cell lung cancer.
Liu TC; Hsieh MJ; Wu WJ; Chou YE; Chiang WL; Yang SF; Su SC; Tsao TC
Int J Med Sci; 2016; 13(12):929-935. PubMed ID: 27994498
[TBL] [Abstract][Full Text] [Related]
16. Survivin expression impacts prognostically on NSCLC but not SCLC.
Rosato A; Menin C; Boldrin D; Dalla Santa S; Bonaldi L; Scaini MC; Del Bianco P; Zardo D; Fassan M; Cappellesso R; Fassina A
Lung Cancer; 2013 Feb; 79(2):180-6. PubMed ID: 23218791
[TBL] [Abstract][Full Text] [Related]
17. Association of BIRC5 Gene Polymorphism with the Collateral Circulation and Severity of Large Artery Atherosclerotic Stroke.
Huang J; Li X; Zhao J; Chen H; Yun Y; Yang G; Jiang Y; Pan Y; Yuan S; Huang J; Su L; Wu Y; Lu D; Xu A; Meng L
Int J Clin Pract; 2022; 2022():9177545. PubMed ID: 35685607
[TBL] [Abstract][Full Text] [Related]
18. [Influence of genetic variation of programmed death-ligand 1 (PD-L1) on the prognosis of patients with non-small cell lung cancer who received platinum-based adjuvant chemotherapy].
Zhang GW; Cheng RR; Zhang FR; Li P; Chu HY; Song XJ; Zhang GJ
Zhonghua Yi Xue Za Zhi; 2020 Sep; 100(34):2682-2688. PubMed ID: 32921017
[No Abstract] [Full Text] [Related]
19. Genetic variants of NBS1 predict clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer in Chinese.
Xu JL; Hu LM; Huang MD; Zhao W; Yin YM; Hu ZB; Ma HX; Shen HB; Shu YQ
Asian Pac J Cancer Prev; 2012; 13(3):851-6. PubMed ID: 22631660
[TBL] [Abstract][Full Text] [Related]
20. The role of expression and polymorphism of the BAG-1 gene in response to platinum-based chemotherapeutics in NSCLC.
Wang YD; Ha MW; Cheng J; Zhang WL; Cong X; Tong CY; Sun J
Oncol Rep; 2012 Apr; 27(4):979-86. PubMed ID: 22179630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
